Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

The future of multipurpose prevention technology product strategies: understanding the market in parallel with product development.

Romano JW, Van Damme L, Hillier S.

BJOG. 2014 Oct;121 Suppl 5:15-8. doi: 10.1111/1471-0528.12850. No abstract available.

2.

Non-specific microbicide product development: then and now.

Romano JW, Robbiani M, Doncel GF, Moench T.

Curr HIV Res. 2012 Jan 1;10(1):9-18. Review.

3.

Pharmacokinetics of 2 dapivirine vaginal microbicide gels and their safety vs. Hydroxyethyl cellulose-based universal placebo gel.

Nel AM, Smythe SC, Habibi S, Kaptur PE, Romano JW.

J Acquir Immune Defic Syndr. 2010 Oct;55(2):161-9. doi: 10.1097/QAI.0b013e3181e3293a.

PMID:
20574411
4.

Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days.

Nuttall JP, Thake DC, Lewis MG, Ferkany JW, Romano JW, Mitchnick MA.

Antimicrob Agents Chemother. 2008 Mar;52(3):909-14. Epub 2007 Dec 17.

5.

In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials.

Tien D, Schnaare RL, Kang F, Cohl G, McCormick TJ, Moench TR, Doncel G, Watson K, Buckheit RW, Lewis MG, Schwartz J, Douville K, Romano JW.

AIDS Res Hum Retroviruses. 2005 Oct;21(10):845-53.

PMID:
16225411
6.

Expression, purification, and characterization of recombinant cyanovirin-N for vaginal anti-HIV microbicide development.

Colleluori DM, Tien D, Kang F, Pagliei T, Kuss R, McCormick T, Watson K, McFadden K, Chaiken I, Buckheit RW Jr, Romano JW.

Protein Expr Purif. 2005 Feb;39(2):229-36.

PMID:
15642474
7.

Chemokine receptor CCR5 Delta 32 genetic analysis using multiple specimen types and the NucliSens Basic Kit.

Tetali S, Lee EM, Kaplan MH, Romano JW, Ginocchio CC.

Clin Diagn Lab Immunol. 2001 Sep;8(5):965-71.

8.

Detection of dengue viral RNA using a nucleic acid sequence-based amplification assay.

Wu SJ, Lee EM, Putvatana R, Shurtliff RN, Porter KR, Suharyono W, Watts DM, King CC, Murphy GS, Hayes CG, Romano JW.

J Clin Microbiol. 2001 Aug;39(8):2794-8.

9.

RANTES and MIP-1beta mRNA expression in human peripheral blood mononuclear cells: transcript quantification using NASBA technology.

Romano JW, Shurtliff RN, Lee EM, Cornelison R, Than S, Kaplan MH, Ginocchio CC.

J Immunol Methods. 2001 Sep 1;255(1-2):115-24.

PMID:
11470292
10.

Macrophage-derived chemokine gene expression in human and macaque cells: mRNA quantification using NASBA technology.

Romano JW, Shurtliff RN, Grace M, Lee EM, Ginocchio C, Kaplan M, Pal R.

Cytokine. 2001 Mar 21;13(6):325-33.

PMID:
11292315
11.

Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology.

Romano JW, Shurtliff RN, Dobratz E, Gibson A, Hickman K, Markham PD, Pal R.

J Virol Methods. 2000 Apr;86(1):61-70.

PMID:
10713377
12.

Genotyping of the CCR5 chemokine receptor by isothermal NASBA amplification and differential probe hybridization.

Romano JW, Tetali S, Lee EM, Shurtliff RN, Wang XP, Pahwa S, Kaplan MH, Ginocchio CC.

Clin Diagn Lab Immunol. 1999 Nov;6(6):959-65.

13.
14.

Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.

Oliva A, Kinter AL, Vaccarezza M, Rubbert A, Catanzaro A, Moir S, Monaco J, Ehler L, Mizell S, Jackson R, Li Y, Romano JW, Fauci AS.

J Clin Invest. 1998 Jul 1;102(1):223-31.

15.

Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma.

Ginocchio CC, Wang XP, Kaplan MH, Mulligan G, Witt D, Romano JW, Cronin M, Carroll R.

J Clin Microbiol. 1997 Nov;35(11):2886-93.

16.

NASBA technology: isothermal RNA amplification in qualitative and quantitative diagnostics.

Romano JW, Williams KG, Shurtliff RN, Ginocchio C, Kaplan M.

Immunol Invest. 1997 Jan-Feb;26(1-2):15-28.

PMID:
9037609
17.

NASBA: a novel, isothermal detection technology for qualitative and quantitative HIV-1 RNA measurements.

Romano JW, van Gemen B, Kievits T.

Clin Lab Med. 1996 Mar;16(1):89-103. Review.

PMID:
8867585
18.

Detection of HIV-1 infection in vitro using NASBA: an isothermal RNA amplification technique.

Romano JW, Shurtliff RN, Sarngadharan MG, Pal R.

J Virol Methods. 1995 Aug;54(2-3):109-19.

PMID:
8530563
19.

p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines.

Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RV, Ullrich S, Romano JW, Appella E, Testa JR, et al.

Cancer Res. 1991 Aug 1;51(15):4090-6.

20.

Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.

Mercer WE, Shields MT, Amin M, Sauve GJ, Appella E, Romano JW, Ullrich SJ.

Proc Natl Acad Sci U S A. 1990 Aug;87(16):6166-70.

21.

Wild type human p53 is antiproliferative in SV40-transformed hamster cells.

Mercer WE, Amin M, Sauve GJ, Appella E, Ullrich SJ, Romano JW.

Oncogene. 1990 Jul;5(7):973-80.

PMID:
2165234
22.

Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line.

Romano JW, Ehrhart JC, Duthu A, Kim CM, Appella E, May P.

Oncogene. 1989 Dec;4(12):1483-8.

PMID:
2531855
23.

Linkage of the mouse Hsp84 heat shock protein structural gene to the H-2 complex.

Romano JW, Seldin MF, Appella E.

Immunogenetics. 1989;29(2):142-4. No abstract available.

PMID:
2563356

Supplemental Content

Loading ...
Support Center